Thursday, August 11, 2016

Bioentrepreneur Contents: August 2016

If you are unable to see the message below, click here to view.
Bioentrepreneur

Latest Article

Where the bodies lie
Some suggestions for avoiding common mistakes made in life sciences startups.


SciCafé

Startups on the menu: Atreca


Trade Secrets Blog

The Bioentrepreneur blog, Trade Secrets, boasts contributors from around the globe, providing regular insight and commentary from those helping build the world's biotechnology sectors.


Podcast

The new episode of Nature Biotechnology's First Rounders podcast: David Baltimore is president emeritus of the California Institute of Technology, where he runs his lab. He is also a Nobel Prize winner, for work he conducted while at the Massachusetts Institute of Technology on the reverse transcriptase enzyme. His First Rounders conversation touches on his parents moving him from New York City to Great Neck, Long Island, as a child; his initial interest in animal virology; and getting that Nobel call from Sweden.

View more articles




You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For other enquiries, please contact our customer feedback department

Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located The Campus, 4 Crinan Street, London, N1 9XW.
© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.
nature publishing group

No comments: